- ￥297 - 9270
- TargetMol
- 美国
- T3042
- 2025年07月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
JAK2 Inhibitor V
- 库存：
10
- 供应商：
TargetMol
- CAS号：
195371-52-9
- 规格：
2 mg/50 mg/1 mL/25 mg/5 mg/500 mg/10 mg/100 mg
| 规格： | 2 mg | 产品价格： | ￥297.0 |
|---|---|---|---|
| 规格： | 50 mg | 产品价格： | ￥2890.0 |
| 规格： | 1 mL | 产品价格： | ￥547.0 |
| 规格： | 25 mg | 产品价格： | ￥1490.0 |
| 规格： | 5 mg | 产品价格： | ￥497.0 |
| 规格： | 500 mg | 产品价格： | ￥9270.0 |
| 规格： | 10 mg | 产品价格： | ￥747.0 |
| 规格： | 100 mg | 产品价格： | ￥4280.0 |
Product Introduction
Bioactivity
英文名:JAK2 Inhibitor V
描述:JAK2 Inhibitor V (JAK2 Inhibitor V Z3) is a novel specific inhibitor of Jak2, inhibiting Jak2-V617F and Jak2-WT autophosphorylation in a dose-dependent manner.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Methods for the Detection of the JAK2 V617F Mutation in Human Myeloproliferative Disorders
A single acquired mutation in the JAK2 gene has recently been described in human myeloproliferative disorders, including most patients with polycythemia vera and about half of those with essential thrombocythemia and idiopathic myelofibrosis
Recently, a point mutation in the JAK2 gene, JAK2 V617F , was discovered in several myeloid proliferative neoplasms including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Demonstration
Methods for Detecting Mutations in the Human JAK2 Gene
for each application. Two commonly used methods, quantitative real-time PCR (QPCR) for the detection of the JAK2 V617F mutation and high resolution melt-curve analysis (HRM) for the detection of multiple mutations within JAK2 exon 12, demonstrate the utility
技术资料暂无技术资料 索取技术资料
